Michiel van den Brekel

The Netherlands Cancer Institute

Professor Michiel van den Brekel is a head and neck surgeon at the department of Head & Neck Oncology & Surgery of the Netherlands Cancer Institute in Amsterdam. Since 2009 he is the chairman of this department.

In 2011 he was appointed as Professor at the University of Amsterdam (Institute of Phonetic Sciences) for ‘Oncology related voice and speech disorders’. His clinical research focuses on rehabilitation of head and neck cancer patients. He is also active in translational research, imaging and HPV research. To date 5 graduate students completed their thesis under his supervision and 26 Head & Neck Fellowships were supervised by him.

He is a member of various international/national head and neck societies and presented basic and clinical research papers at many international meetings. He (co-)authored over 200 papers peer-reviewed papers and various book chapters and serves as a reviewer for a number of clinical scientific journals.

dont miss

Vocal and pulmonary rehabilitation after total laryngectomy

In this seminar I will give an update on the possibilities of both vocal and pulmonary rehabilitation after total laryngectomy. Recent developments in voice rehabilitation, as well as adverse events and the management of complications will be discussed.

EVEN MORE SEMINARS

  • Dr Tom Newsom-Davis: Speaking at the Oncology Convention

    Dr Tom Newsom-Davis
    Leaders in Oncology Care (Part of HCA healthcare UK)

    Immunotherapy and innovative systemic treatments in Oncology

  • Chris Curtis: Speaking at the Oncology Convention

    Chris Curtis
    The Swallows Head & Neck Cancer Charity

    A patient’s journey ‘Cancer to the palace in 6yrs’

  • Gareth Thomas BDS, MScD, PhD, FDSRCS, FRCPath: Speaking at the Oncology Convention

    Gareth Thomas BDS, MScD, PhD, FDSRCS, FRCPath
    University Hospital Southampton NHS Foundation Trust.

    Targeted therapies: aiming at the tumour micro-environment

  • Professor A. Graham Pockley: Speaking at the Oncology Convention

    Professor A. Graham Pockley
    multimmune GmbH / Nottingham Trent University

    A new era of cancer therapeutics?

  • Glenn Flux: Speaking at the Oncology Convention

    Glenn Flux
    Royal Marsden Hospital

    The emergence and resurgence of radiotherapeutics for cancer treatment